Canary Medical Announces Introduction of Groundbreaking Orthopedic Analytic Platform

Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, announced the introduction of its first orthopedic analytic module, Canary Quantiles™ Recovery Curves. Recovery curves utilize movement data measured by Canary Medical’s proprietary implantable canturio™te tibial extension sensor technology integrated with Zimmer Biomet’s Persona IQ® – The Smart Knee®...READ MORE

Donation to UBC Medicine is World’s Largest Known Gift for MS Research

A $33.8 million gift has been donated to the UBC Faculty of Medicine and VGH & UBC Hospital Foundation for multiple sclerosis (MS) research and care — the largest known donation ever for MS research worldwide. The private donation was made by a B.C.-based philanthropist who believes comprehensive contributions to science and medicine can quickly advance solutions and treatments across diseases for patients in B.C., across Canada and around the world...READ MORE

Evonik Launches Plant-Based Squalene to Boost Vaccine Efficacy

Evonik has launched a non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene® is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene. Non-GMP samples of PhytoSquene® are available immediately with GMP quality to follow in 2023...READ MORE

New Data for Trodelvy Demonstrate Clinical Efficacy Across Trop-2 Expression Levels in HR+/HER2- Metastatic Breast Cancer

Gilead Sciences announced new data from a post-hoc analysis from the Phase 3 TROPiCS-02 study evaluating Trodelvy® (sacituzumab govitecan-hziy; SG) versus comparator chemotherapy (physicians’ choice of chemotherapy, TPC) in patients with HR+/HER2- metastatic breast cancer who progressed on endocrine-based therapies and at least two chemotherapies. In the analysis, Trodelvy improved progression-free survival, overall survival and objective response rate compared with TPC across Trop-2 expression levels...READ MORE

Sernova Corp. Announces CEO Succession Plan and Expanded Management Team

Sernova Corp., a clinical-stage company and leader in cell therapeutics, announced that, as part of a planned leadership succession process, and after a successful 13-year tenure leading the Company through the development of its pioneering Cell Pouch SystemTM and ensuing growth, Dr. Philip Toleikis, President and Chief Executive Officer will be appointed Sernova’s Chief Technology Officer (CTO)....READ MORE

Algernon Pharmaceuticals Receives U.S. FDA Orphan Drug Designation for Ifenprodil for the Treatment of Idiopathic Pulmonary Fibrosis

Algernon Pharmaceuticals Inc., a Canadian clinical stage pharmaceutical development company, announce that the United States FDA has granted Orphan Drug Designation to Ifenprodil as a treatment for Idiopathic Pulmonary Fibrosis (IPF). Ifenprodil is the sole active ingredient in NP-120, an NMDA receptor antagonist and the Company’s lead clinical candidate being developed for the treatment of IPF and chronic cough...READ MORE

Ondine Reports Full Results from Phase 2 Nasal Photodisinfection Trial

Ondine Biomedical reports the full results of its Phase 2 BENEFIT-PDT clinical trial, which met the primary endpoint of bacterial load reduction after nasal photodisinfection. The anterior nares (nostrils) are considered a primary reservoir of pathogens including Staphylococcus aureus and multidrug-resistant S. aureus – the leading cause of surgical site infections After all patients were included in the analysis, including those enrolled but not treated due to rescheduled surgeries, Photodisinfection was found to have eliminated or significantly decreased S. aureus in 86% of carriers (p<0.01)…READ MORE

LIVTENCITY™ (maribavir) Receives Positive CADTH Recommendation for Adults with Post-Transplant Cytomegalovirus (CMV) Infection

Takeda Canada Inc. announce that the Canada’s Drug and Health Technology Agency (CADTH) Canadian Drug Expert Committee (CDEC) recommends LIVTENCITY™ (maribavir) for public reimbursement. The recommendation is for the treatment of post-transplant cytomegalovirus (CMV) in adults. Following Health Canada’s priority review, which concluded in September 2022, LIVTENCITY was authorized for the treatment of adults with post-transplant CMV infection/disease who are refractory (with or without genotypic resistance) to one or more prior antiviral therapies…READ MORE

Acuitas Therapeutics Co-Authoring a Study That Shows Early Promise for an mRNA Vaccine Targeting All Known Flu Strains

A new study co-authored by scientists from the University of Pennsylvania and Vancouver-based biotechnology firm Acuitas Therapeutics shows early promise for an mRNA vaccine targeting all known flu strains. The study provides data from pre-clinical trials and shows that the vaccine produces high levels of antibodies against all known strains of the flu, which may allow for a universal flu shot in the future...READ MORE

Improving Health Outcomes for Patients Living With Interstitial Lung Disease and Addressing the Gaps in Care is the Aim of a New Collaboration

Boehringer Ingelheim (Canada) Ltd. and the Firestone Institute for Respiratory Health are collaborating to bring an innovative health solution for patients living with interstitial lung disease to address crucial care gaps. The CONNECT-ILD project will use innovative technology—Seamless MD—that enables remote patient management, peer-to-peer community support, patient education, and multi-disciplinary discussions to provide patients with another pathway to access the care they need...READ MORE

New Cabinet Ready to Take Action on Cost of Living, Health Care, Housing, Climate

Premier David Eby has announced a new cabinet made of experience and new energy that will focus on tackling the problems people are facing, and working to make life better for British Columbians. “British Columbia is a wonderful place to live, but people are looking for action on the issues facing them and their families,” Premier Eby said. “If the pandemic taught us anything, it’s that we can’t solve these problems alone. We need to solve them together. My team of determined colleagues will use a wealth and variety of experiences to continue the good work we’ve started and go further to deliver results people can see and feel in their communities.”...READ MORE

Province Partners with YVR to Electrify, Reduce Emission

A new government initiative will create jobs and economic opportunities for British Columbians by supporting made-in-B.C. companies to develop and sell clean-tech solutions locally, so they can solve industry challenges. As part of the StrongerBC Economic Plan, the Integrated Marketplace Initiative kicks off with a pilot project that links Vancouver International Airport to B.C. clean-technology companies that can help electrify its operations to meet its net-zero by 2030 commitment and become the world’s greenest airport...READ MORE

Technician, Process Development

Avivo are seeking a highly motivated Technician to join the Process Development and Analytic team at Avivo. In this capacity, the Technician will support the development of upstream and downstream processes, as well as impurity assay development to support the ongoing development of our bacterial-produced enzyme-based product. These activities will involve a combination of protein biochemistry, enzymology and molecular biology. An ideal candidate must be able to take initiative in problem solving, prioritise assignments, work efficiently under time constraints, and work within teams and with minimum supervision.

LEARN MORE

Director/VP Clinical Operations

This job posting is for a full-time (1.0 FTE) position. The successful candidate must have excellent organizational and time management skills, self-responsibility and accountability, and ability to interact positively with other team members are absolutely required. This position requires a proven ability to multi-task efficiently and to ensure that Qu’s SSI immunotherapy platform is fully supported with respect to developing and implementing the strategies required to successfully execute Qu Biologic’s clinical studies. The candidate will work as part of a growing team in a very busy biopharmaceutical company environment. You will report directly to the CEO.

LEARN MORE

Director/VP Manufacturing

This job posting is for a full-time (1.0 FTE) position. The successful candidate will play an essential role in creating documentation and maintaining compliance consistent with GLP and cGMP standards for pre-clinical, early and late-stage clinical development, including pre-IND/CTA meetings from early stage through Phase 3 clinical development and support regulatory submissions.

The successful candidate will also play an essential role in communicating CMC progress and strategy to Qu Biologics’ Board of Directors, shareholders, and potential investors and Pharma partners.

LEARN MORE

Xybion is a global SaaS company that helps enterprise life sciences organizations accelerate new drug development into approved medicines that saves lives and keeps employees safe. Our intelligent cloud platform digitizes drug research and development, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a single, unified cloud platform that is cost-effective, ready to deploy, and easy to use.

Visit Website

Avantor®, a Fortune 500 company, is a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 225,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. Our leading global customer channel, VWR, offers an integrated, seamless purchasing experience. 

Visit Website